Chongqing Polycomp International Corporation (SHE:301526)
12.96
-0.11 (-0.84%)
Mar 5, 2026, 4:00 PM EST
SHE:301526 Revenue
Chongqing Polycomp International had revenue of 2.26B CNY in the quarter ending September 30, 2025, with 18.30% growth. This brings the company's revenue in the last twelve months to 8.39B, up 15.47% year-over-year. In the year 2024, Chongqing Polycomp International had annual revenue of 7.36B with 2.87% growth.
Revenue (ttm)
8.39B
Revenue Growth
+15.47%
P/S Ratio
5.64
Revenue / Employee
1.41M
Employees
5,932
Market Cap
47.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.36B | 205.48M | 2.87% |
| Dec 31, 2023 | 7.16B | -737.90M | -9.35% |
| Dec 31, 2022 | 7.89B | -406.25M | -4.89% |
| Dec 31, 2021 | 8.30B | 1.39B | 20.09% |
| Dec 31, 2020 | 6.91B | 1.43B | 26.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Sanjiu Medical & Pharmaceutical | 31.63B |
| Hunan Yuneng New Energy Battery Material | 29.95B |
| Beijing New Building Materials | 25.36B |
| Shenzhen Everwin Precision Technology | 18.84B |
| Sichuan Kelun Pharmaceutical | 18.30B |
| Shenzhen Kaifa Technology | 15.25B |
| China Greatwall Technology Group | 14.89B |
| Sangfor Technologies | 8.01B |